Parkside Financial Bank & Trust’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$99.7K	Buy	4,027 +889	+28%	+$21.2K	0.01%	683
2025 Q4	$73.2K	Buy	3,138 +469	+18%	+$10.4K	0.01%	814
2025 Q3	$52.6K	Sell	2,669 -150	-5%	-$3.08K	﹤0.01%	910
2025 Q2	$61.2K	Sell	2,819 -18	-0.6%	-$425	0.01%	828
2025 Q1	$68.8K	Buy	2,837 +182	+7%	+$4.1K	0.01%	718
2024 Q4	$55.4K	Hold	2,655	–	–	0.01%	766
2024 Q3	$52.8K	Buy	2,655 +418	+19%	+$7.75K	0.01%	762
2024 Q2	$34.7K	Sell	2,237 -438	-16%	-$6.82K	0.01%	870
2024 Q1	$42.6K	Buy	2,675 +812	+44%	+$12.2K	0.01%	786
2023 Q4	$31.3K	Buy	+1,863	New	+$25.5K	0.01%	842
2023 Q2	–	Sell	-132	Closed	-$2.19K	–	2029
2023 Q1	$2.19K	Hold	132	–	–	﹤0.01%	1676
2022 Q4	$2.46K	Hold	132	–	–	﹤0.01%	1608
2022 Q3	$2K	Buy	+132	New	+$1.56K	﹤0.01%	1517